Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
12.17
+0.96 (8.56%)
At close: Mar 9, 2026, 4:00 PM EDT
12.31
+0.14 (1.15%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Generate Biomedicines Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 1,551 | - | - |
| Enterprise Value | 1,398 | - | - |
| Debt / Equity Ratio | 0.36 | 0.36 | 0.22 |
| Net Debt / Equity Ratio | -0.81 | -0.81 | -0.89 |
| Net Debt / EBITDA Ratio | 0.69 | 0.69 | 1.74 |
| Net Debt / FCF Ratio | 0.75 | 0.75 | 2.61 |
| Asset Turnover | 0.08 | 0.08 | - |
| Quick Ratio | 2.70 | 2.70 | 4.55 |
| Current Ratio | 2.85 | 2.85 | 4.70 |
| Return on Equity (ROE) | -81.72% | -81.72% | - |
| Return on Assets (ROA) | -34.63% | -34.63% | - |
| Return on Capital Employed (ROCE) | -94.80% | -94.80% | -45.60% |
| Buyback Yield / Dilution | - | -2.77% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.